This highlights the reproducibility of fibroblast clusters of the skin with scRNA seq (healthy and disease), as well as shared pathophysiology between the two sclerodermatous disorders since potentially pathogenic fibroblasts, such as Cluster 8 (SFRP4/PRSS23), were identified in both conditions, SSc and LS. Here, PRSS23 is linked to systemic sclerosis.